Bibliografia
1. Vos T et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990- 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
2. Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013 Jan 10;14(1):1.
3. Stovner LJ, Andrée C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010;11:289-99
4. Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210
5. ISTAT. Condizioni di salute e ricorso ai servizi sanitari. Anno 2005.
6. Roncolato M, Fabbri L, Recchia G, Cavazzuti L, Visona G, Brignoli O, Medea G. An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPs. Eur Neurol 2000; 43:102-106.
7. Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005 Jun;12 Suppl 1:1-27.
8. Olesen J. The International Classification of Headache Disorders, 2nd edition: application to practice. Funct Neurol. 2005 Apr-Jun;20(2):61-8.
9. Società Italiana per lo Studio delle Cefalee (SISC). Linee Guida per la diagnosi e la terapia delle cefalee primarie. 2011.
10. Raggi A, Giovannetti AM, Quintas R, D’Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain. 2012;13(8):595-606.
11. Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84:422-35.
12. Steiner TJ. Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide. J Headache Pain 2005;6:373-7.
13. Dueland AN, Leira R, Burke TA, Hillyer EV, Bolge S. The impact of migraine on work, family, and leisure among young women - a multinational study. Curr Med Res Opin. 2004;20(10):1595-604.
14. Sullivan S. J. Promoting Health and Productivity for Depressed Patients in the Workplace. Manag Care Pharm. 2005;11(suppl):S12-S15.
15. Burton WN wt al. The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research. Mayo Clin Proc. 2009;84(5):436- 445.
16. Kaczynski KJ, Claar RL, Lebel AA. Relations between pain characteristics, child and parent variables, and school functioning in adolescents with chronic headache: a comparison of tensiontype headache and migraine. J Pediatr Psychol. 2013;38(4):351-64.
17. Kantor D. The impact of migraine on school performance. Neurology. 2012;79(18):e168-9.
18. Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population based studies in the USA and UK. Cephalalgia 2003;23:429–440.
19. Esposito M, Gallai B, Parisi L, Castaldo L, Marotta R, Lavano SM, Mazzotta G, Roccella M, Carotenuto M. Self-concept evaluation and migraine without aura in childhood. Neuropsychiatr Dis Treat. 2013;9:1061-6.
20. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306(6890):1437- 40.
21. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002 Oct;22(8):633-58.
22. Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache. 2007 Sep;47(8):1152-68.
23. Amoozegar F, Pringsheim T. Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life. Patient Prefer Adherence. 2009 Nov 3;3:251-8.
24. Baos V, Serrano A, Torrecilla M, Bertral C, Caloto MT, Nocea G, Gerth WC; I-MAX Study Group. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting. Int J Clin Pract. 2003 Nov;57(9):761-8.
25. Bussone G, D’Amico D, McCarroll KA, Gerth W, Lines CR. Restoring migraine sufferers’ ability to function normally: a comparison of rizatriptan and other triptans in randomized trials. Eur Neurol. 2002;48(3):172-7.
|